Fischer Medical Ventures Allots 60 Lakh Equity Shares on Warrant Conversion, Raises ₹10.53 Crore
Fischer Medical Ventures Limited converted 60 lakh warrants into equity shares on March 31, 2026. Promoter Mr. Shankar Varadharajan exercised the option, raising ₹10.53 crore for the company. The issue price was ₹23.40 per share.
The fundraising amount of ₹10.53 crore is significant for a company of this size and can impact its financial flexibility and growth initiatives. The conversion by a promoter also signals confidence.
The company successfully raised capital through the conversion of warrants into equity shares, which is generally positive for financial health and growth prospects.
Fischer Medical Ventures Limited has announced the conversion of 60,00,000 (Sixty Lakhs) convertible warrants into equity shares. The Board of Directors, through a circular resolution dated March 31, 2026, approved this allotment. Each equity share has a face value of ₹1 and was issued at a price of ₹23.40 per share, including a premium of ₹22.40 per share.
The conversion was made for cash, with the receipt of the remaining exercise price of ₹17.55 per warrant, which is 75% of the total exercise price. This aggregated to ₹10,53,00,000 (Rupees Ten Crores Fifty-Three Lakhs).
The allottee is Mr. Shankar Varadharajan, who belongs to the Promoter Category. He converted 60,00,000 warrants into equity shares, contributing the total consideration of ₹10,53,00,000. The company secretary and compliance officer, Mr. Balaji Gandla, signed the disclosure.
What to do with a filing like this
Fischer Medical Ventures Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fischer Medical Ventures Limited. Read the original for the full detail.